<DOC>
	<DOCNO>NCT02627898</DOCNO>
	<brief_summary>Type 2 diabetes mellitus ( T2DM ) become epidemic XXI century . This chronic disease also highly prevalent primarily associate increase cardiovascular mortality morbidity due micro macrovascular complication , pathophysiological mechanism accelerate formation atherosclerotic process , fundamental element associate arterial stiffness . The importance anticipate presence cardiovascular event lie precisely early detection subclinical change elastic artery identify measure pulse wave velocity . Having adequate pharmacological non-pharmacological intervention impact precisely reduction pulse wave velocity contributes reduction cardiovascular morbidity mortality associate DM2 . Among non-pharmacological therapy study benefit attribute use green tea infusion either encapsulate extract associate mainly anti-inflammatory antioxidant effect . There experimental clinical study show benefit administration green tea ( extract infusion ) , administer different route different dosage vary time . But noted study green tea meet appropriate draw conclusion benefit cardiovascular level . However , propose use green tea extract high amount catechin control clinical trial could potential therapeutic strategy change hemodynamic alteration arterial stiffness favorably particular group patient DM2 .</brief_summary>
	<brief_title>Effect Green Tea Extract Arterial Stiffness Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>The objetive evaluate effect administration Green tea exctract arterial stiffness individual T2DM . The investigator conduct double-blind trial , randomize , placebo control group , group 12 male female patient 35-65 year age T2DM , hypertension treat insulin . Randomization determine receive intervention 8 week trial ( Green tea extract capsule , 400 mg 1 time daily first bite meal approve placebo capsule ) , group also continue usual treatment . The clinical finding laboratory test include metabolic profile biosafety , wich baseline 8 week . Body weight , body fat , body mass index ( BMI ) blood pressure determine inicial final visit , likewise , hemodynamics parameter arterial stiffness like aortic pulse wave velocity ( PWVao ) , central pulse pressure ( PPao ) , aortic augmentation index ( IAxao ) central systolic blood pressure ( cSBP ) oscillometric monitor system via BPLab Â® . Adverse event adherence treatment document . The statistical analysis : Mann-Whitney U Test Wilcoxon exact test . It consider significance p &lt; 0.05 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Diagnosis T2DM Fasting plasma glucose &gt; 126 &lt; 250 mg/dl time security Metformin monotherapy glibenclamide add Written informed consent Hypertention Treated insulin Use antioxidant suplements product caffeine Woman pregnant breastfeeding Untreated tyroid disease Total colesterol &gt; 400mg/dl Triglycerides &gt; 400mg/dl Liver enzimes ( alt ast ) tan twice normal range Glomerular filtration rate &lt; 60ml/min ( CockcroftGault )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Green tea extract</keyword>
	<keyword>Arterial stiffness</keyword>
	<keyword>PWVao</keyword>
</DOC>